Mon. May 25th, 2026
Spread the love

A federal judge has ruled that the Trump administration can share location data about undocumented immigrants who receive Medicaid or any other public health insurance benefits with Immigration and Customs Enforcement (ICE). It’s a significant blow for California Attorney General Rob Bonta and his 21 other Democratic counterparts, who sued the administration in July to prevent the administration from using Medicaid data to target undocumented immigrants.

According to Politico, California, along with other states, sued the Trump administration following reports that the Department of Health and Human Services (HHS) was sharing personal data collected from undocumented Medicaid enrollees with the Department of Homeland Security (DHS).

U.S. District Judge Vince Chhabria, appointed by former President Barack Obama, initially blocked the Trump administration from sharing personal information for immigration enforcement temporarily in August. However, he changed his tune after ICE and HHS leaders published formal notices in November detailing how they plan to use Medicaid data for immigration purposes.

“The sharing of such information is clearly authorized by law, and the agencies have adequately explained their decisions,” Chhabria wrote in his updated ruling Monday.

While undocumented immigrants are not eligible to enroll in federal Medicaid programs, some states allow people to receive state-funded benefits regardless of immigration status. These states include California, Illinois, Colorado, New York, Washington, Oregon, and Minnesota, as well as Washington, D.C.

Chharbria’s order covers six categories of basic personal information, including citizenship, immigration status, address, phone number, date of birth, and Medicaid ID, according to Courthouse News Service. However, the judge sided with the states regarding data beyond basic information. According to the judge’s ruling, the Trump administration is only allowed to share Medicaid data about people unlawfully living in the United States. This means ICE cannot access personal information collected from other immigrants receiving Medicaid.

In addition, ICE and HHS remain barred from sharing personal health records and other potentially sensitive medical information for immigration enforcement under the judge’s preliminary injunction. Chhabria said the agencies did not provide a compelling reason for exchanging such information. California and other states argued that sharing this information would violate health privacy laws.

The California Attorney General’s Office told Courthouse News that it is disappointed with the judge’s decision.

“When individuals signed up for Medi-Cal, they did so with the understanding that their data would not be used for purposes unrelated to administering the program,” a spokesperson told Courthouse News Service. “The Trump administration’s effort to use Medicaid data for immigration enforcement is a violation of their trust and will lead to fewer people seeking vital health care, harming the overall health of our communities and increasing public health costs to the state.”

RELATED CONTENT: Trump Says He May Open Medicare and Medicaid To 30 Million Uninsured Americans

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.